ticlopidine has been researched along with Thalassemias in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ticlopidine treatment did not significantly improve platelet life-span or factor VIII levels, though it was associated with reduced values of beta TG and PF4." | 2.65 | A double-blind trial of ticlopidine in sickle cell disease. ( Al-Hasani, SF; Kioy, P; Savidge, GF; Semple, MJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semple, MJ | 1 |
| Al-Hasani, SF | 1 |
| Kioy, P | 1 |
| Savidge, GF | 1 |
1 trial available for ticlopidine and Thalassemias
| Article | Year |
|---|---|
A double-blind trial of ticlopidine in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anticoagulants; Blood Coagulation Factors; Blood Platelets; Cell Surviva | 1984 |